INS and diabetes mellitus: The longer duration of diabetes has a detrimental impact on glycemic control, likely due to the progressive decline in insulin secretion over time as a consequence of beta-cell dysfunction [16]. Drug utilization patterns also affect outcomes, with monotherapy generally achieving better control than combination therapies.